HDMA honors AmerisoureBergen's Yost with Nexus Award
AmerisourceBergen CEO has had a 37-year career in healthcare distribution
At HDMA’s annual Business & Leadership Conference this week, HDMA’s research arm, the Center for Healthcare Supply Chain Research, and its industry sponsor, Genentech, Inc., honored Yost with the 2011 Nexus Award for Lifetime Achievement. The award recognizes leadership in the healthcare industry and HDMA, as well as community involvement and professional accomplishment.
R. David Yost, has been CEO of AmerisourceBergen since its origin in the merger of AmeriSource Health and Bergen Brunswig Corp. in 2001. He started in the industry in 1974 as a salesman at a predecessor company to AmeriSource, eventually rising to chairman and CEO of AmeriSource. AmerisourceBergen is today a $78-billion company, No. 27 on the Fortune 500. Yost is also on the board of directors of the International Federation of Pharmaceutical Wholesalers, Tyco Corp., the Board of Trustees of Penn Medicine, and a founding director of the United States Air Force Academy Endowment Board. He is a graduate of the Air Force Academy, and has an MBA from UCLA.
“Dave embodies all of the attributes of the Nexus Award through his industry and community leadership,” said HDMA President and CEO John M. Gray. “Throughout his distinguished career he has been a tireless champion for distributors and the customers they serve, yet through all his success and accomplishment, has remained humble and dedicated to his family and community.”
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
